Recent advances of antibody-drug conjugates in treating breast cancer with different HER2 status
Despite the availability of multiple treatment options for breast cancer, challenges such as adverse events, drug resistance, and disease progression persist for patients. The identification of human epidermal growth factor receptor 2 (HER2) as an oncogenic driver in a subset of breast cancers, alon...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publishing
2025-01-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Acceso en liña: | https://doi.org/10.1177/17588359241311379 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|